Trinity Biotech (TRIB) Interest Coverage Ratio Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) Interest Coverage Ratio Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 43.57% |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -142.87% |
| Sep 30, 2024 | 34.03% |
| Jun 30, 2024 | 121.99% |
| Mar 31, 2024 | 86.90% |
| Dec 31, 2023 | 39.79% |
| Sep 30, 2023 | 31.08% |
| Jun 30, 2023 | 125.51% |
| Mar 31, 2023 | 46.09% |
| Dec 31, 2022 | -42.97% |
| Sep 30, 2022 | 75.70% |
| Jun 30, 2022 | 30.62% |
| Mar 31, 2022 | 27.93% |
| Dec 31, 2021 | 53.73% |
| Sep 30, 2021 | -20.41% |
| Jun 30, 2021 | 52.49% |
| Mar 31, 2021 | -17.75% |
| Dec 31, 2020 | -120.73% |
| Sep 30, 2020 | -78.80% |
| Jun 30, 2020 | 36.03% |
| Mar 31, 2020 | -7.12% |